Amirhossein Mahfoozi

Cedars-Sinai Medical Center

Papers

1

Total Citations

5

H-Index

1

About

Amirhossein Mahfoozi is a rising surgical researcher whose work focuses on the intersection of thoracic oncology and minimally invasive surgical innovation. His primary research areas include robotic-assisted surgery, lung cancer treatment, and the evolving role of segmentectomy in early-stage non-small cell lung cancer (NSCLC). His most cited paper, "Trends in segmentectomy for the treatment of stage 1A non-small cell lung cancers: Does the robot have an impact?" (2022, 5 citations), investigates how robotic technology is reshaping surgical approaches for early-stage lung cancer. This work contributes to a critical shift in thoracic surgery, where parenchymal-sparing segmentectomy is increasingly favored over lobectomy for small tumors, and examines whether robotic platforms enhance adoption and outcomes. While his citation count is modest, reflecting his early career stage, Mahfoozi’s research addresses a timely and clinically relevant question—how technological advances can improve precision and recovery in lung cancer surgery. His work is valuable for students and researchers interested in the convergence of surgical technique, technology assessment, and oncologic outcomes, offering insights into the future of personalized, minimally invasive thoracic care.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Trends in segmentectomy for the treatment of stage 1A non-small cell lung cancers: Does the robot have an impact?
5 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Cedars-Sinai Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago